Bunny Hill
L1 2.0 fentanyl hr747-119

Stop Chinese Fentanyl Act of 2025

Why China-relevant: To impose sanctions with respect to Chinese producers of synthetic opioids and opioid precursors, to hold Chinese officials accountable ... includes— (i) any entity of the People's Republic of China that the President determines ... produces, manufactures, distributes, sells, or knowingly finances or transports [opioid

Sponsor: Barr, Andy (R-KY) · 9 cosponsors bipartisan

Path to becoming law

  1. Introduced
  2. Passed committee
  3. Passed House
  4. Passed Senate next step
  5. Sent to President
  6. Became law

done next step still ahead

Legislative timeline — dated actions so far

  1. Filed
  2. Advanced in committee
  3. Advanced in committee
  4. Passed chamber (vote) [house]
Stage: Passed House

4% to become law · 25% to clear committee

For context: only ~2% of introduced bills ever become law, so every estimate starts near that baseline — the factors below show what moves this bill above or below the average bill.

  • + Bipartisan support (2/9 cosponsors from across the aisle)
  • + Unified government (sponsor's party controls House, Senate, and White House)
  • + Sponsor's party controls both chambers
  • + Broad cosponsorship (9 cosponsors)
  • − No companion bill in the other chamber

Legislative likelihood — a tracking indicator, not investment advice.

Signals — secondary, directional

PRC retaliation risk medium Hawkishness 4

Directional context (see Methodology); the pinned, high-confidence axes are relevance and asset impact.

Shares that might be influenced

Each sector shows a direction (which way its China-related names are pushed) and, for precise mappings, how hard this bill hits the sector — rated marginal → very strong (1–5). Hover any chip for its definition. The headline 0–5 impact is at the top of the card.

China Pharma negative coarse 806 names

Sector-level estimate — mapped by policy area, not from this bill's specific text.

Top 10 of 806 by market cap Full roster · Premium

Ticker Name (Local) Name (EN) Restriction Lists
688235.SS 百济神州 BEONE MEDICINES
600276.SS 恒瑞医药 HENGRUI PHARMA
603259.SS 药明康德 WuXi AppTec 1260H
3692.HK 翰森制药 Hansoh Pharmaceutical Group Company Limited
300760.SZ 迈瑞医疗 MR
2269.HK 药明生物 WUXI BIOLOGICS (CAYMAN) INC.
1801.HK 信达生物 Innovent Biologics, Inc.
6618.HK 京东健康 JD Health International Inc.
6990.HK 科伦博泰生物 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
9926.HK 康方生物 Akeso,Inc.
+796 more